 Home > Medical News > Latest Medical News > CDE issued the notice of "Suspension of Review Timing and Restoration of Management Practices in the Process of Drug Evaluation by the State Medical Products Administration (Trial)"

CDE issued the notice of "Suspension of Review Timing and Restoration of Management Practices in the Process of Drug Evaluation by the State Medical Products Administration (Trial)"

 Last Update: 2022-11-26
 Source: Internet
 Author: User

Tags

flovent drug class

mph drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Notice of the Center for Drug Review of the State Food and Drug Administration on the issuance of the "Management Practice for Suspension and Restoration of Review Timing in the Process of Drug Evaluation of the State Medical Products Administration (Trial)" (Drug Review Industry [2022] No.
614)

Release date: 20221116

In order to standardize the suspension and resumption of review timing management in the review process and ensure the legality, compliance, fairness and justice of the drug review process, under the unified deployment of the State Medical Products Administration, the Drug Review Center formulated the "Management Specification for the Suspension and Restoration of Review Timing in the Process of Drug Evaluation of the State Medical Products Administration (Trial)
".
After the review and approval of the State Medical Products Administration, it is hereby released and will be implemented
from the date of promulgation.

Annex: Management Practices for Suspension and Restoration of Review Timing in the Drug Evaluation Process of the State Medical Products Administration (Trial)

Drug Review Center, State Food and Drug Administration

November 15, 2022

Related attachments

serial number	Attachment name
1	During the drug review process of the State Medical Products Administration, the review timing was suspended and the management practice (trial) was . pdf

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.